Suppr超能文献

采用竞争法和直接微酶联免疫吸附测定技术检测儿童体内的HIV抗体。

HIV-antibody detection in children by competitive and direct micro-ELISA techniques.

作者信息

Voiculescu C, Turculeanu A, Bălăşoiu M, Filipaş L

机构信息

Faculty of Medicine, Department of Microbiology, Craiova, Romania.

出版信息

Rev Roum Virol. 1992 Jan-Jun;43(1-2):67-72.

PMID:1288641
Abstract

A comparative study was carried out on 110 sera from children or infants, suspected of HIV-antibody presence following several micro-ELISA assays, using four direct micro-ELISA (Wellcozyme HIV 1 + 2, Rapid Elavia Mixt, Ortho Diagnostics, RECVIH) and a competitive system--Wellcozyme-Recombinant. In three of the four direct systems, as well as in the competitive system, significantly higher mean values of sample/cut off, and cut off/sample ratios, respectively, as compared to the direct systems RECVIH, were present. High optimal levels of sensitivity and specificity (%), as related to Western Blot results, were found with Wellcozyme direct and competitive kits, as well as with Rapid Elavia Mixt kit, as compared to lower levels exhibited by the other two direct system kits (Ortho Diagnostics an especially RECVIH). As regards three Western Blot undetermined results, obtained in patients with a severe clinical state and evolution to exitus, by comparing some serological markers of HIV infection in two serum samples belonging to the same case (second sample collected 4 weeks after collection of the first homologous sample), the disappearance of gag-encoded-p24 band in Western Blot, associated with negativation of HIV-p24-antibody and with the presence of free virus antigen in all three second serum samples occurred, that would reflect a probable fall of immune anti-HIV "barriers" during final stages of illness. Although Western Blot confirmation cannot be excluded, it seems to be useful to assay comparatively HIV-antibody presence by means of direct and competitive micro-ELISA systems, in the same serum sample.

摘要

对110份儿童或婴儿血清进行了一项比较研究,这些血清在经过多次微量酶联免疫吸附测定后怀疑存在HIV抗体。使用了四种直接微量酶联免疫吸附测定法(Wellcozyme HIV 1 + 2、Rapid Elavia Mixt、Ortho Diagnostics、RECVIH)和一种竞争系统——Wellcozyme - 重组体。与直接系统RECVIH相比,在四种直接系统中的三种以及竞争系统中,样本/临界值和临界值/样本比值的平均值分别显著更高。与其他两种直接系统试剂盒(Ortho Diagnostics尤其是RECVIH)所表现出的较低水平相比,发现Wellcozyme直接和竞争试剂盒以及Rapid Elavia Mixt试剂盒与免疫印迹结果相关的敏感性和特异性(%)具有较高的最佳水平。对于在临床状态严重且病情发展至死亡的患者中获得的三个免疫印迹未确定结果,通过比较同一病例的两份血清样本(第一份同源样本采集后4周采集第二份样本)中的一些HIV感染血清学标志物,发现免疫印迹中gag编码的p24条带消失,同时HIV - p24抗体呈阴性,且所有三份第二份血清样本中均存在游离病毒抗原,这可能反映了疾病终末期免疫抗HIV“屏障”的可能下降。尽管不能排除免疫印迹确认,但在同一血清样本中通过直接和竞争微量酶联免疫吸附系统比较检测HIV抗体的存在似乎是有用的。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验